Divi's Laboratories Limited has informed the Exchange regarding 'Compliance of Regulation 30(5) of SEBI (LODR) Regulations, 2015 - contact details of the officials for the purpose of determining materiality of an event or information and to make disclosures to Stock Exchanges.
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories submitted a routine compliance filing to NSE and BSE under SEBI Regulation 30(5) on August 6, 2025. The Board of Directors, at its meeting held on the same day, amended the company's Policy on Determination of Materiality Disclosure of Events or Information. The filing lists seven Key Managerial Personnel authorized to determine the materiality of any event or information, including Managing Director Dr. Murali K. Divi, Executive Director Mr. N.V. Ramana, CEO Dr. Kiran S. Divi, and Whole-Time Directors. For actually making disclosures to stock exchanges, only two officials are authorized — CFO Mr. Venkatesa Perumarthy Pasumarthy and Company Secretary Mr. M. Satish Choudhury. A shared contact number (+9140 66966352) and email addresses were also provided.
This is a routine regulatory compliance update with no direct impact on business operations, financials, or shareholder value. Investors should note this is administrative in nature and does not signal any new corporate event, strategy change, or material development.